Nutralife Biosciences Inc (NLBS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2021 | 12-2020 | 12-2019 | 12-2018 | 12-2017 | |
| Sales | 627 | 1,256 | 2,134 | 3,711 | 1,790 |
| Cost of Goods | 543 | 746 | 1,536 | 2,211 | 1,055 |
| Gross Profit | 84 | 510 | 598 | 1,500 | 735 |
| Operating Expenses | 5,099 | 3,229 | 4,529 | 3,617 | 21,080 |
| Operating Income | -4,473 | -1,973 | -3,395 | -1,906 | -20,290 |
| Interest Expense | 0 | 0 | 8 | 3 | 3,342 |
| Other Income | -1,355 | -917 | -604 | -166 | 3 |
| Pre-tax Income | -5,828 | -2,890 | -4,007 | -2,075 | -23,629 |
| Net Income Continuous | -5,828 | -2,890 | -4,007 | -2,075 | -23,629 |
| Net Income | $-5,828 | $-2,890 | $-4,007 | $-2,075 | $-23,629 |
| EPS Basic Total Ops | -0.04 | -0.02 | -0.04 | -0.02 | -0.33 |
| EPS Basic Continuous Ops | -0.04 | -0.02 | -0.04 | -0.02 | -0.33 |
| EPS Diluted Total Ops | -0.04 | -0.02 | -0.04 | -0.02 | -0.33 |
| EPS Diluted Continuous Ops | -0.04 | -0.02 | -0.04 | -0.02 | -0.33 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.02 | -0.04 | -0.02 | -0.33 |
| EBITDA(a) | $-3,708 | $-907 | $-2,579 | $-1,734 | $-19,352 |